Work

Blinatumomab combined with low-dose chemotherapy and TKI as first-line induction for newly diagnosed ph+ b-ALL: Improved efficacy and reduced toxicity

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-5130

Authors: Zhenshu Xu, Shujuan Xu, Xinxin Liu, Ping Weng, Qiaoqiao Song, Guangyao Guo, Bihong Cai, Zezhong Yu, Huijian Zheng, Nainong Li

Institutions: Fujian Medical University, Union Hospital, Shandong First Medical University, Hubei University of Science and Technology

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417018121

Cites:

Cited by:

Related to: